360 digital solutions powered by AI to fight Antimicrobial Resistance
Leveraging lessons learnt from COVID-19 response to tackle the silent pandemic of AntiMicrobial Resistance (AMR)
It’s time
to talk about
AMR
Spearhead is initiated Innovation Office, University of Basel
Our
Mission
Spearhead aims to tackle the silent pandemic of antimicrobial resistance by developing innovative multidisciplinary research-based digital solutions that addresses stewardship and prevention.
A fact:
4.95 million deaths associated with bacterial resistance in 2019
Our
goals
Spearhead will leverage big data, machine learning, rapid diagnostics and digital media to help doctors make quick and effective treatment choices, and patients and citizens to become more confident in the usage of antibiotics.
The project has five main goals
1
Real-time data
flow to and from
decision-makers
2
Utilise rapid diagnostics to identify the right treatment at the right time
3
Leverage big data and artificial intelligence for risk prediction and improve
efficacy of antibiotics
4
Early attention to the financial implications of the proposed innovations
5
Empower citizens with knowledge and awareness to make medications more
effective
OUR
SOLUTIONS
Spearhead is working to slow down antibiotic resistance through the development of a novel risk prediction
model and rapid diagnostics for doctors that allow for personalized care, while also engaging patients and citizens for better treatment outcomes.
Spearhead aims to equip:
Doctors
-
A risk predictive model coupled with real-time surveillance to allow data-driven decision makingin treating infections;
-
And rapid diagnostics that can leapfrog a centralised laboratory infrastructure.
patients and citizens
-
More information and knowledge about antibiotic usage and resistance through more engaging channels such as social media and innovative digital formats.
healthcare
budget-holders
-
A cost-effective model solution to tackle AMR
Who
we
are
Spearhead is a consortium of 12 Swiss-based partners from academics and industry, with multidisciplinary expertise across research in infectious diseases and microbiology, pharmaceuticals, med tech, machine learning and artificial intelligence, innovative design and digital communications.
Makeaware
Using stories and data sharing to empower people in the fight against antimicrobial resistance.